Page 11234..10..»

Archive for the ‘Stem Cell kidney Failure’ Category

R3 International Offering Stem Cell Therapy Program for Anti Aging in Mexico – PR Web

Tuesday, June 30th, 2020

Anti Aging Stem Cell Therapy in Mexico (888) 988-0515 SAN DIEGO (PRWEB) June 24, 2020 R3 Stem Cell International announced a new program offering stem cell therapy for anti aging in Mexico. The program offers several options with stem cell counts up to 200 million and pricing starting at $2950. To date, R3 International has been offering stem cell therapy in Mexico successfully for many conditions including autism, COPD, kidney failure, liver disease, heart conditions, dementia, stroke, neuropathy and arthritis just to name a few.

Read More...

FDA Approves Merck’s KEYTRUDA (pembrolizumab) for First-Line Treatment of Patients With Unresectable or Metastatic MSI-H or dMMR Colorectal Cancer -…

Tuesday, June 30th, 2020

KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that the U.S.

Read More...

Vitro Bio-Pharma 2nd Quarter Ended April 30th 2020 Financial Results of Operations and Shareholder Letter – Stockhouse

Tuesday, June 30th, 2020

GOLDEN, COLO / ACCESSWIRE / June 29, 2020 / Vitro Diagnostics, Inc. (OTCQB:VODG), dba Vitro Biopharma, announced its 2nd quarter ended April 30th 2020 financial results of operations. Vitro Diagnostics Inc

Read More...

FDA Approves Merck’s KEYTRUDA (pembrolizumab) for the Treatment of Patients with Recurrent or Metastatic Cutaneous Squamous Cell Carcinoma (cSCC) that…

Thursday, June 25th, 2020

KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced today that the U.S.

Read More...

Simcha Therapeutics Launches to Engineer Therapeutic Cytokines to Unlock the Full Potential of the Immune System – Business Wire

Thursday, June 25th, 2020

NEW HAVEN, Conn.--(BUSINESS WIRE)--Simcha Therapeutics, a biotechnology company developing first-in-class biologic drugs that modulate powerful cytokine pathways, launched today with $25 million in Series A financing and a mission to harness the precision and power of the immune system through the use of directed evolution. Simchas lead program involves a customized variant of interleukin-18 (IL-18), a cytokine with potent antitumor effects, developed in the lab of Scientific Founder Aaron Ring, M.D., Ph.D., Assistant Professor of Immunobiology at the Yale School of Medicine

Read More...

First American to Receive Placental Cell Treatment For COVID-19 is an Acclaimed Broadway Scenic Designer – Science Times

Wednesday, May 27th, 2020

Edward Pierce, 49, an acclaimed Broadway set designer for plays like Wicked spent five weeks in a medically induced coma after contracting COVID-19 and was treated at a hospital in Teaneck, New Jersey. His condition slowly deteriorated due to organ failure, and there seemed to be little hope, so his wife agreed to use an untested method developed by an Israeli biotechnology firm. He made history as the first American to receive placental cells in around 15 parts of his body.

Read More...

Scientists generate millions of mature human cells, far more than have ever been produced – UB News Center

Wednesday, May 20th, 2020

BUFFALO, N.Y. For decades, the enormous disease-curing potential of human stem cells has been thwarted by the inability to produce sufficient quantities of mature human cells in vivo in a living organism. Now, a team led by University at Buffalo scientists has developed a method that dramatically ramps up production of mature human cells in mouse embryos

Read More...

Heres The Reason Why Scientists Are Growing Human Cells In Mouse Embryo – Medical Daily

Wednesday, May 20th, 2020

Scientists have placed more mature human cells in mouse embryos. The progress is expected to help the medical community improve the development of treatments, including those for COVID-19

Read More...

Cell therapies trial planned for COVID-19 – Mirage News

Tuesday, May 5th, 2020

More than 200,000 people have died from COVID-19 since January 2020. While Australia has been relatively spared from the onslaught of infections and deaths, our nations scientists need to be part of the global effort to address this pandemic. Research Group Head, Amnion Cell Biology There is no effective treatment to address the ongoing damage caused by for severe COVID-19 infections, said Associate Professor Rebecca Lim, Research Group Head of Amnion Cell Biology at Hudson Institute

Read More...

New Study Finds That Wearing Contact Lenses Doesn’t Increase Risk of COVID-19 Infection – HealthDay Coronavirus Liveblog

Sunday, April 26th, 2020

Each week, HealthDay's Physician's Briefing division rounds up the most important COVID-19 developments in the medical field. See this week's edition below for April 20-April 24. FDA Warns About Treating COVID-19 With Unproven Drugs FRIDAY, April 24, 2020 (HealthDay News) -- Malaria drugs touted by some as potential "game changers" against COVID-19 are actually too dangerous for general use, the U.S.

Read More...

Israeli COVID-19 treatment with 100% survival rate tested on US patient – The Jerusalem Post

Wednesday, April 15th, 2020

Israeli-based Pluristem has treated its first American patient suffering from COVID-19 complications under the countrys compassionate use program.The news comes days after a report by the company showed that six critically ill coronavirus patients in Israel who are considered high-risk for mortality were treated with Pluristems placenta-based cell-therapy product and survived, according to preliminary data provided by the Haifa-based company.In the US case, the patient was treated with the companys PLX cell therapy at Holy Name Medical Center in New Jersey, where Pluristem is already running a Phase III critical limb ischemia study. Like the patients treated in Israel, this patient was critically ill with respiratory failure due to acute respiratory distress syndrome and was intubated in an intensive care unit for three weeks.The companys president and CEO, Yaky Yanay, said that although Pluristem is focused on a planned multinational clinical trial for the treatment of complications associated with coronavirus, it does hope to expand treatment under compassionate use in other countries at the same time.

Read More...

Stem Cells and Chronic Kidney Disease | Mayo Clinic Center …

Saturday, April 11th, 2020

Millions of Americans have chronic kidney disease. Hundreds of thousands will progress to end stage kidney disease requiring either dialysis or kidney transplant.

Read More...

Kidney Failure | Stem Cell Treatment in Tijuana Mexico

Saturday, April 11th, 2020

Current treatment options often fail due to the progression of renal disease.

Read More...

MESOBLAST PARTNERS WITH THE CARDIOTHORACIC SURGICAL TRIALS NETWORK ESTABLISHED BY THE U.S. NATIONAL INSTITUTES OF HEALTHS NATIONAL HEART, LUNG AND…

Saturday, April 11th, 2020

NEW YORK, April 08, 2020 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB) today announced that its allogeneic mesenchymal stem cell (MSC) product candidate remestemcel-L will be formally evaluated in a randomized, placebo-controlled trial in 240 patients with acute respiratory distress syndrome (ARDS) caused by coronavirus infection (COVID-19). This multi-center Phase 2/3 trial will be conducted as a public-private partnership in a collaboration with the Cardiothoracic Surgical Trials Network (CTSN), which was established by the United States National Institutes of Healths National Heart, Lung and Blood Institute (NHLBI) as a flexible platform for conducting collaborative trials.

Read More...

Merck Receives Priority Review from FDA for Second Application for KEYTRUDA (pembrolizumab) Based on Biomarker, Regardless of Tumor Type – Benzinga

Saturday, April 11th, 2020

Supplemental Biologics License Application (sBLA) Accepted for KEYTRUDA Monotherapy in Patients Whose Tumors Are Tumor Mutational Burden-High (TMB-H) Who Have Progressed Following Prior Treatment Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has accepted and granted priority review for a new supplemental Biologics License Application (sBLA) for KEYTRUDA, Merck's anti-PD-1 therapy

Read More...

A coronavirus vaccine is being developed in record time. But dont expect that technology to speed up flu vaccines yet. – Columbia Daily Herald

Tuesday, April 7th, 2020

Imagine generating a vaccine for the novel coronavirus from your immune system. The virus that causes COVID-19 has swept the globe with about 1.3 million infections and 70,000 deaths through Sunday evening.Development of a widely available vaccine can take a year or more while a virus continues its rampage. Key to the race to develop a vaccine for the new coronavirus is a technology that uses the virus' genetic code to essentially persuade your body to make its own vaccine

Read More...

Researchers test drug that stops early stages of COVID-19 – Open Access Government

Tuesday, April 7th, 2020

This research was partly funded by the Federal Canadian government, to support the development, testing and implementation of ways to manage the pandemic. Rumours have been circulating social media platforms at the speed of light, discussing the imminence or the impossibility of a real cure. Here, we discuss the ongoing research of a trial drug that is biologically capable of preventing fatalities from Coronavirus.

Read More...

Can cell-based therapy be helpful in tackling coronavirus? – YourStory

Wednesday, March 25th, 2020

Ever since the novel coronavirus, or COVID-19, was first reported in China's Wuhan city, the virus has spread to more than 196 countries and territories around the world with393,284 confirmed cases and17,161 deaths so far. In India, the maximum number of cases has been reported in the state of Maharashtra.The number of coronavirus cases in the country has risen to 519, with 10 deaths. It is the need of the hour to find a solution for coronavirus.

Read More...

Made-in-space organs could soon be reality – ETHealthworld.com

Friday, March 13th, 2020

Astronauts are growing the beginnings of new organs on board the International Space Station. The experiment is an attempt to grow human tissue by sending adult human stem cells into space, and allowing them to grow in space. Eventually, it is hoped, the stem cells will develop into bone, cartilage and other organs

Read More...

What Is the Coronavirus? – WIRED

Friday, March 6th, 2020

If you're confused, think about HIV/AIDS. Human-immunodeficiency virus infects people

Read More...

Page 11234..10..»


2020 © StemCell Therapy is proudly powered by WordPress
Entries (RSS) Comments (RSS) | Violinesth by Patrick